New Zealand markets open in 6 hours 40 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4000+0.1300 (+10.24%)
As of 11:20AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
144,951
148,757
164,522
143,006
95,388
Cost of revenue
38,628
38,826
41,305
34,686
22,074
Gross profit
106,323
109,931
123,217
108,320
73,314
Operating expenses
Research development
176,047
186,602
257,707
283,146
231,347
Selling general and administrative
127,672
128,400
163,894
182,769
175,781
Total operating expenses
318,962
330,222
425,405
475,626
407,128
Operating income or loss
-212,639
-220,291
-302,188
-367,306
-333,814
Interest expense
32,817
31,673
23,491
16,547
13,183
Total other income/expenses net
-11,001
-10,534
-37,063
-11,915
-20,404
Income before tax
-258,806
-264,928
-369,759
-398,626
-367,401
Income tax expense
-390
-404
-547
1,798
608
Income from continuing operations
-258,416
-264,524
-369,212
-400,424
-368,009
Net income
-258,416
-264,524
-369,212
-400,424
-368,009
Net income available to common shareholders
-258,416
-264,524
-369,212
-400,424
-368,009
Basic EPS
-
-2.29
-4.38
-7.43
-7.07
Diluted EPS
-
-2.29
-4.38
-7.43
-7.07
Basic average shares
-
115,528
84,307
53,873
52,066
Diluted average shares
-
115,528
84,307
53,873
52,066
EBITDA
-
-224,759
-338,070
-374,311
-349,617